Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?-Reference-Cited by-同舟云学术

Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Published:2019-08-19 Issue:10 Volume:73 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Citrome Leslie¹^ORCID

Affiliation:

1. New York Medical College Valhalla NY USA

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13397

Reference24 articles.

1. US FDA. NDA 204370/S‐006.Supplemental Approval Letter. May 24 2019.https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/204370Orig1s006ltr.pdf. Accessed July 5 2019.

2. Allergan.VRAYLAR (cariprazine) capsules for oral use. Prescribing information. May 2019.https://www.allergan.com/assets/pdf/vraylar_pi. Accessed July 4 2019.

3. Treatment of bipolar depression: making sensible decisions;Citrome L;CNS Spectr,2014

4. Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

5. Cariprazine for the Treatment of Schizophrenia: A Review of this Dopamine D3-Preferring D3/D2 Receptor Partial Agonist

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Pharmacologic Approaches to the Treatment of Bipolar Depression;Drugs;2023-05-25

2. Assessing effectiveness of endoscope-assisted medial orbital wall fracture repair vs. no surgery using benefit-risk metrics and literature review;Journal of Stomatology, Oral and Maxillofacial Surgery;2023-02

3. Dental Screening Including Panoramic Radiograph for Gorlin-Goltz Syndrome in Patients With Multiple Basal Cell Carcinomas;Journal of Cutaneous Medicine and Surgery;2022-10-07

4. Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents;Frontiers in Pharmacology;2022-06-14

5. Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?;Frontiers in Psychiatry;2022-01-25